生物学和材料科学的融合:生物分子驱动的智能药物输送系统
Yaqin Hou1,2, Xiaolei Yu3
1Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China.
Biomolecules
|October 29, 2025
概括
生物分子驱动的智能材料通过创建响应生物线索的可编程系统来彻底改变药物输送. 这些先进的纳米材料为治疗癌症和炎症等疾病提供了更高的特异性和有效性.
科学领域:
- 生物材料科学 生物材料科学
- 药理学 药理学是指药理学的学科.
- 纳米技术纳米技术
背景情况:
- 智能材料正在将药物交付从被动干预转变为积极的可编程干预.
- 生物分子驱动系统利用核酸,,蛋白质和多糖为目标反应.
- 这些材料被设计成能够感知并响应特定的病理生理学线索或外部触发因素.
研究的目的:
- 为制药学中生物分子驱动的智能材料提供全面的审查.
- 根据它们对内源和外源触发物的反应来对系统进行分类.
- 调查生物分子架构,并讨论治疗应用和挑战.
主要方法:
- 界定刺激响应的启动原理 (内源和外源触发器).
- 生物分子架构的深入调查 (DNA纳米技术,,蛋白质,多糖).
- 讨论治疗应用 (瘤学,炎症性疾病,基因治疗) 和挑战 (生物相容性,可扩展性,调节性).
主要成果:
- 智能材料的分类基于对pH,氧化还原,酶,ROS,温度,光和磁场的反应.
- 探索DNA纳米技术,/蛋白质和基于多糖的系统.
- 突出成功的应用,克服生物障碍,提高治疗效果.
结论:
- 生物分子驱动的智能材料代表了精密医学的重大进步.
- 未来的方向包括多刺激响应系统,逻辑门设计和人工智能驱动的个性化纳米药物.
- 应对挑战对于将这些创新从实验室转化为临床实践至关重要.
相关概念视频
Cellular Membranes and Drug Transport
1.4K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.4K
Drug Delivery: Overview
718
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
718
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
171
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
171
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
1.6K
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
1.6K
Bioavailability Enhancement: Drug Permeability Enhancement
183
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
183
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193


